Award

82203024

Funder: National Natural Science Foundation of China

Funded outputs count: 5

Funder award ID: 82203024

OpenAlex ID: G2330761237

Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway

2025 · Jie Wu, Nian Liu, et al. · Journal for ImmunoTherapy of Cancer · 23

Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma

2024 · Nian Liu, Mingjie Yan, et al. · Biomaterials · 24

Ferroptosis and tumor immunity.

2024 · Qian Tao, Nian Liu, et al. · PubMed Central · 2

Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors

2024 · Qian Tao, Nian Liu, et al. · Journal for ImmunoTherapy of Cancer · 63

Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis

2023 · Nian Liu, Mingjie Yan, et al. · Journal for ImmunoTherapy of Cancer · 66